Enhancing the clinical translation of stem cell models by focusing on standardization and international regulatory cooperation

doi:10.4252/wjsc.v17.i4.102788

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=0

Apr 26, 2025 (publication date) through Apr 23, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Stem Cells. Apr 26, 2025; 17(4): 102788
Published online Apr 26, 2025. doi: 10.4252/wjsc.v17.i4.102788

Enhancing the clinical translation of stem cell models by focusing on standardization and international regulatory cooperation

Wei Wang, An-Ran Song, Hong-Wen Liu, Yi-Kai Li

Wei Wang, An-Ran Song, Department of Traditional Chinese Medicine, Youyang People’s Hospital, Chongqing 409800, China

Hong-Wen Liu, Yi-Kai Li, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, Guangdong Province, China

Co-corresponding authors: Hong-Wen Liu and Yi-Kai Li.

Author contributions: Wang W and Son g AR participated in drafting the manuscript; Wang W and Liu HW wrote the original draft; Li YK contributed to conceptualization and writing, reviewing, and editing of this manuscript; Liu HW and Li YK made equal contributions to this work and are jointly designated as co-corresponding authors of this manuscript; All authors read and approved the final version of the manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Yi-Kai Li, MD, PhD, Chief Physician, Professor, School of Traditional Chinese Medicine, Southern Medical University, No. 1023 South Shatai Road, Baiyun District, Guangzhou 510515, Guangdong Province, China. ortho@smu.edu.cn

Received: November 1, 2024
Revised: February 12, 2025
Accepted: March 10, 2025
Published online: April 26, 2025
Processing time: 176 Days and 14.9 Hours

Core Tip

Core Tip: Granjeiro et al discussed the role of stem cells in advanced therapy medicinal products for tissue regeneration and drug screening. This article emphasized the importance of international regulatory harmonization and standardized protocols to address current challenges and enhance the global clinical translation, safety, and consistency of stem cell-based therapies.